Autopsy report · NCT02465203
3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study
Cause of deathOther
“Study was prematurely terminated.”
Life of this trial
- Registered 2 years 6 months after it had already started.
- Ran for about 1 year 5 months before it stopped.
- 105 participants enrolled.
- Results were posted on the registry 4 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Hepatitis C, Chronic
- Interventions
- Previous treatment in DEB025 study
- Participants
- 105
- Sites
- 40
- Countries
- Australia, Belgium, Canada, Germany, Hungary, India, Italy, Poland, Puerto Rico, Romania, South Korea, Spain and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.